There were 2,385 press releases posted in the last 24 hours and 440,311 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cellceutix Prepares Phase 2a Ovarian Cancer Trial of Kevetrin, a Novel p53-Modulating Drug Candidate, Based Upon Phase 1 Topline Data

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image